PEREGRINE PHARMACEUTICALS INC·4

Apr 28, 6:58 PM ET

PEREGRINE PHARMACEUTICALS INC 4

4 · PEREGRINE PHARMACEUTICALS INC · Filed Apr 28, 2017

Insider Transaction Report

Form 4
Period: 2017-04-28
Shan Joseph
VP Clin./Regulatory Affs. (3)
Transactions
  • Other

    Common Stock

    2017-04-28$0.27/sh+39,177$10,62594,079 total
Footnotes (1)
  • [F1]Shares acquired under the issuer's employee stock purchase plan on April 28, 2017

Documents

1 file
  • 4
    shan_f4.xmlPrimary

    OWNERSHIP DOCUMENT